Skip to main content
OpenTrials

Clinical trial condition

Progressive Multiple Sclerosis

Explore clinical trials studying Progressive Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

29 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Progressive Multiple Sclerosis trial results

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)

NCT07282574

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Southern Neurology Kogarah, New South Wales, Australia
  • John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Box Hill Hospital Box Hill, Victoria, Australia
  • Austin Health Heidelberg, Victoria, Australia
View all 108 locations
View Trial Details
Recruiting

Obe-cel in Refractory Progressive Forms of Multiple Sclerosis

NCT07139743

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Stanford University Redwood City, California, United States
  • Hospital Universitario Vall d'Hebron - PPDS Barcelona, Spain
  • Hospital Universitari i Politecnic La Fe de Valencia Valencia, Spain
  • Addenbrooke's Hospital Cambridge, United Kingdom
View Trial Details
Active, not recruiting

ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis

NCT04695080

Conditions
Advanced Multiple Sclerosis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +12 more
Locations
  • Queens University Belfast (Belfast Health and Social Care Trust) Belfast, United Kingdom
  • University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham Birmingham, United Kingdom
  • Cardiff University Hospital Cardiff, United Kingdom
  • University Hospitals of Coventry and Warwickshire NHS Trust Coventry, United Kingdom
View all 22 locations
View Trial Details
Active, not recruiting

Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)

NCT06675864

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Novartis Investigative Site Darlinghurst, New South Wales, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Québec, Quebec, Canada
  • Novartis Investigative Site Bron, France
View all 18 locations
View Trial Details

Related conditions